Atlas Trials

A Study to Evaluate the My Hematology Oncology Patient Experience (MyHOPE™) For Multiple Myeloma (MM) Digital Care Network in Patients With MM

Clinical trial NCT04730505 · TERMINATED

Trial details

NCT number
NCT04730505
Sponsor
Celgene
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2021-02-04
Primary completion
2021-06-21
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.